{
    "5-Fluorouracil": {
        "gdsc": [
            "5-Fluorouracil"
        ],
        "type": "Chemotherapy"
    },
    "AMG 510": {
        "gdsc": [
            "KRAS (G12C) Inhibitor-12"
        ],
        "type": "Targeted therapy"
    },
    "AZD3759": {
        "gdsc": [
            "AZD3759"
        ],
        "type": "Targeted therapy"
    },
    "AZD8186": {
        "gdsc": [
            "AZD8186"
        ],
        "type": "Targeted therapy"
    },
    "Abiraterone": {
        "gdsc": [],
        "type": "Hormone therapy"
    },
    "Ado-Trastuzumab Emtansine": {
        "gdsc": [],
        "type": "Hormone therapy"
    },
    "Afatinib": {
        "gdsc": [
            "Afatinib"
        ],
        "type": "Targeted therapy"
    },
    "Alectinib": {
        "gdsc": [
            "Alectinib"
        ],
        "type": "Targeted therapy"
    },
    "Alkylating chemotherapy": {
        "gdsc": [],
        "type": "Chemotherapy"
    },
    "Alpelisib": {
        "gdsc": [
            "Alpelisib"
        ],
        "type": "Targeted therapy"
    },
    "Atezolizumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Azacitidine": {
        "gdsc": [],
        "type": "Chemotherapy"
    },
    "Azacitidine + Panobinostat": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "BAY 1895344": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Barasertib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Bevacizumab": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Bevacizumab + Olaparib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Bleomycin": {
        "gdsc": [
            "Bleomycin"
        ],
        "type": "Chemotherapy"
    },
    "Bortezomib": {
        "gdsc": [
            "Bortezomib"
        ],
        "type": "Targeted therapy"
    },
    "Bosutinib": {
        "gdsc": [
            "Bosutinib"
        ],
        "type": "Targeted therapy"
    },
    "Buparlisib + Trametinib": {
        "gdsc": [
            "Buparlisib",
            "Trametinib"
        ],
        "type": "Targeted therapy"
    },
    "Cabozantinib": {
        "gdsc": [
            "Cabozantinib"
        ],
        "type": "Targeted therapy"
    },
    "Capecitabine + Trastuzumab + Tucatinib": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Capmatinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Carbogen and nicotinamide  + radiotherapy": {
        "gdsc": [],
        "type": "Radiation therapy"
    },
    "Carboplatin": {
        "gdsc": [],
        "type": "Chemotherapy"
    },
    "Ceritinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Cetuximab": {
        "gdsc": [
            "Cetuximab"
        ],
        "type": "Targeted therapy"
    },
    "Cetuximab + Encorafenib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Cetuximab + Vemurafenib": {
        "gdsc": [
            "PLX-4720",
            "Cetuximab"
        ],
        "type": "Targeted therapy"
    },
    "Chemotherapy + Hyaluronidase-zzxf + Pertuzumab + Trastuzumab": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Chemotherapy + Pembrolizumab": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Chemotherapy + Trastuzumab": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Cisplatin": {
        "gdsc": [
            "Cisplatin"
        ],
        "type": "Chemotherapy"
    },
    "Cobimetinib + Vemurafenib": {
        "gdsc": [
            "PLX-4720"
        ],
        "type": "Targeted therapy"
    },
    "Crizotinib": {
        "gdsc": [
            "Crizotinib"
        ],
        "type": "Targeted therapy"
    },
    "Dabrafenib": {
        "gdsc": [
            "Dabrafenib"
        ],
        "type": "Targeted therapy"
    },
    "Dabrafenib + Trametinib": {
        "gdsc": [
            "Dabrafenib",
            "Trametinib"
        ],
        "type": "Targeted therapy"
    },
    "Dacomitinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Danusertib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Dasatinib": {
        "gdsc": [
            "Dasatinib"
        ],
        "type": "Targeted therapy"
    },
    "Docetaxel + Hyaluronidase-zzxf + Pertuzumab + Trastuzumab": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Durvalumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Durvalumab + Gefitinib": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Durvalumab + Osimertinib": {
        "gdsc": [
            "Osimertinib"
        ],
        "type": "Combination therapy"
    },
    "EGF816": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "EPZ015666": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "EXEL-8232": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Enasidenib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Encorafenib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Entrectinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Enzalutamide": {
        "gdsc": [],
        "type": "Hormone therapy"
    },
    "Erdafitinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Erlotinib": {
        "gdsc": [
            "Erlotinib"
        ],
        "type": "Targeted therapy"
    },
    "Everolimus": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "FGFR1 inhibitor + Trametinib": {
        "gdsc": [
            "Trametinib"
        ],
        "type": "Targeted therapy"
    },
    "FGFR1 inhibitor + Trametinib ": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "GANT61": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "GANT61 + Obatoclax": {
        "gdsc": [
            "Obatoclax Mesylate"
        ],
        "type": "Targeted therapy"
    },
    "Gamma knife": {
        "gdsc": [],
        "type": "Radiation therapy"
    },
    "Gefitinib": {
        "gdsc": [
            "Gefitinib"
        ],
        "type": "Targeted therapy"
    },
    "Icotinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Imatinib": {
        "gdsc": [
            "Imatinib"
        ],
        "type": "Targeted therapy"
    },
    "Infigratinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Interferon-alpha + Ixazomib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Ipilimumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Ipilimumab + Nivolumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Ipilimumab + Vemurafenib": {
        "gdsc": [
            "PLX-4720"
        ],
        "type": "Combination therapy"
    },
    "Ivosidenib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "JQ1": {
        "gdsc": [
            "JQ1"
        ],
        "type": "Targeted therapy"
    },
    "LOXO-292": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Lapatinib": {
        "gdsc": [
            "Lapatinib"
        ],
        "type": "Targeted therapy"
    },
    "Lapatinib + Trastuzumab": {
        "gdsc": [
            "Lapatinib"
        ],
        "type": "Targeted therapy"
    },
    "Larotrectinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Lenalidomide": {
        "gdsc": [
            "Lenalidomide"
        ],
        "type": "Targeted therapy"
    },
    "Letrozole": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Letrozole + Tamoxifen": {
        "gdsc": [
            "Tamoxifen"
        ],
        "type": "Combination therapy"
    },
    "Lorlatinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "MK-2206": {
        "gdsc": [
            "MK-2206"
        ],
        "type": "Targeted therapy"
    },
    "Margetuximab-cmkb + Chemotherapy": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Mito-CP": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Momelotinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Neoadjuvant chemoradiation": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Neoadjuvant chemotherapy + surgery": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Neratinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Neratinib + Vemurafenib": {
        "gdsc": [
            "PLX-4720"
        ],
        "type": "Targeted therapy"
    },
    "Nilotinib": {
        "gdsc": [
            "Nilotinib"
        ],
        "type": "Targeted therapy"
    },
    "Niraparib": {
        "gdsc": [
            "Niraparib"
        ],
        "type": "Targeted therapy"
    },
    "Nivolumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Nivolumab + Pembrolizumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Olaparib": {
        "gdsc": [
            "Olaparib"
        ],
        "type": "Targeted therapy"
    },
    "Olmutinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Omacetaxine": {
        "gdsc": [],
        "type": "Chemotherapy"
    },
    "Omipalisib": {
        "gdsc": [
            "Omipalisib"
        ],
        "type": "Targeted therapy"
    },
    "Osimertinib": {
        "gdsc": [
            "Osimertinib"
        ],
        "type": "Targeted therapy"
    },
    "PF-06747775": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "PU-H71": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Palbociclib": {
        "gdsc": [
            "Palbociclib"
        ],
        "type": "Targeted therapy"
    },
    "Palbociclib + Trametinib": {
        "gdsc": [
            "Palbociclib",
            "Trametinib"
        ],
        "type": "Targeted therapy"
    },
    "Panitumumab": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Pazopanib": {
        "gdsc": [
            "Pazopanib"
        ],
        "type": "Targeted therapy"
    },
    "Pembrolizumab": {
        "gdsc": [],
        "type": "Immunotherapy"
    },
    "Pemigatinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Pertuzumab + Trastuzumab": {
        "gdsc": [],
        "type": "Combination therapy"
    },
    "Pictilisib": {
        "gdsc": [
            "Pictilisib"
        ],
        "type": "Targeted therapy"
    },
    "Platinum": {
        "gdsc": [],
        "type": "Chemotherapy"
    },
    "Ponatinib": {
        "gdsc": [
            "Ponatinib"
        ],
        "type": "Targeted therapy"
    },
    "Pralsetinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Proton-based SBRT": {
        "gdsc": [],
        "type": "Radiation therapy"
    },
    "Quizartinib": {
        "gdsc": [
            "Quizartinib"
        ],
        "type": "Targeted therapy"
    },
    "Radiation therapy": {
        "gdsc": [],
        "type": "Radiation therapy"
    },
    "Radical radiotherapy": {
        "gdsc": [],
        "type": "Radiation therapy"
    },
    "Regorafenib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Rociletinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Rucaparib": {
        "gdsc": [
            "Rucaparib"
        ],
        "type": "Targeted therapy"
    },
    "Ruxolitinib": {
        "gdsc": [
            "Ruxolitinib"
        ],
        "type": "Targeted therapy"
    },
    "SBRT": {
        "gdsc": [],
        "type": "Radiation therapy"
    },
    "SU11274": {
        "gdsc": [
            "SU11274"
        ],
        "type": "Targeted therapy"
    },
    "Selpercatinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Selumetinib": {
        "gdsc": [
            "Selumetinib"
        ],
        "type": "Targeted therapy"
    },
    "Selumetinib + Vemurafenib": {
        "gdsc": [
            "PLX-4720",
            "Selumetinib"
        ],
        "type": "Targeted therapy"
    },
    "Sirolimus": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Sorafenib": {
        "gdsc": [
            "Sorafenib"
        ],
        "type": "Targeted therapy"
    },
    "Sunitinib": {
        "gdsc": [
            "Sunitinib"
        ],
        "type": "Targeted therapy"
    },
    "Talazoparib": {
        "gdsc": [
            "Talazoparib"
        ],
        "type": "Targeted therapy"
    },
    "Tamoxifen": {
        "gdsc": [
            "Tamoxifen"
        ],
        "type": "Hormone therapy"
    },
    "Tazemetostat": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Tofacitinib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Trametinib": {
        "gdsc": [
            "Trametinib"
        ],
        "type": "Targeted therapy"
    },
    "Trametinib + Vemurafenib": {
        "gdsc": [
            "PLX-4720",
            "Trametinib"
        ],
        "type": "Targeted therapy"
    },
    "Trastuzumab": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "U0126": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "VX-680": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Vandetanib": {
        "gdsc": [],
        "type": "Targeted therapy"
    },
    "Veliparib": {
        "gdsc": [
            "Veliparib"
        ],
        "type": "Targeted therapy"
    },
    "Vemurafenib": {
        "gdsc": [
            "PLX-4720"
        ],
        "type": "Targeted therapy"
    },
    "nutlin-3": {
        "gdsc": [
            "Nutlin-3a (-)"
        ],
        "type": "Targeted therapy"
    }
}